Metabolic signaling pathways

Metabolic signaling pathways encompass the complex network of biochemical reactions and signaling cascades that regulate cellular energy homeostasis, nutrient uptake, and macromolecule synthesis (NCBI, NBK21161). Key pathways include the insulin/IGF-1 signaling, mTOR (mechanistic target of rapamycin), AMPK (AMP-activated protein kinase), and PPAR (peroxisome proliferator-activated receptor) pathways (Nature Reviews Molecular Cell Biology, 2017). These systems integrate extracellular signals, such as hormones and nutrient availability, to coordinate physiological responses across various tissues. Dysregulation of these pathways is a hallmark of numerous metabolic disorders, including type 2 diabetes, obesity, and non-alcoholic fatty liver disease, as well as being heavily implicated in cancer metabolism (StatPearls, NBK459248). While these pathways are critical therapeutic areas, they are typically addressed by targeting specific enzymes or receptors within the network rather than the pathway as a whole (PubMed, 30215149). Consequently, pharmacological intervention requires high specificity to avoid broad systemic toxicity and unintended metabolic consequences (Cell Metabolism, 2018). From a drug development perspective, these pathways offer a wealth of targets, but the complexity of feedback loops often leads to resistance or compensatory mechanisms.

Other names

Metabolic pathwaysCellular metabolism signalingNutrient sensing pathwaysMetabolic networks

Pharmacological agents typically target specific enzymes, receptors, or transporters within these pathways to modulate metabolic flux, such as activating AMPK or inhibiting mTOR (Nature Reviews Drug Discovery, 2018).